Author:
Iwamoto Hideki,Itano Satoshi,Itano Osamu,Ishii Masatsugu,Niizeki Takashi,Shirono Tomotake,Shimose Shigeo,Suzuki Hiroyuki,Kajiwara Akira,Yamaguchi Taizo,Koga Hironori,Torimura Takuji
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference19 articles.
1. Torimura T, Iwamoto H. Optimizing the management of intermediate-stage HCC: current trends and prospects. Clin Mol Hepatol. 2020;27(2):236–45 (Epub 2020/12/03).
2. Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30(7):560–6.
3. Nakano M, Niizeki T, Nagamatsu H, Tanaka M, Kuromatsu R, Satani M, et al. Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: a prospective cohort study. Mol Clin Oncol. 2017;7(6):1013–20 (Epub 2017/10/04).
4. Liu M, Shi J, Mou T, Wang Y, Wu Z, Shen A. Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis. J Gastroenterol Hepatol. 2020;35(8):1277–87 (Epub 2020/02/13).
5. Hu J, Bao Q, Cao G, Zhu X, Yang R, Ji X, et al. Hepatic arterial infusion chemotherapy using oxaliplatin plus 5-fluorouracil versus transarterial chemoembolization/embolization for the treatment of advanced hepatocellular carcinoma with major portal vein tumor thrombosis. Cardiovasc Intervent Radiol. 2020;43(7):996–1005 (Epub 2020/01/23).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献